Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 66, Issue 20, Pages 3387-3398Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-009-0119-y
Keywords
Red blood cells; T cells; Cell growth; Survival; Cyclosporine A
Categories
Funding
- Associacao Portuguesa Contra a Leucemia (APCL, Portugal [APCL2006-30.1.AP/MJ]
- Fundacao para a Ciencia e a Tecnologia [SFRH/BD/24524/2005]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/24524/2005] Funding Source: FCT
Ask authors/readers for more resources
Red blood cells (RBC) have emerged as a novel regulatory cell type endowed with bioactivities toward activated human T cells. Herein we show that the RBC bioactivities act on intracellular pathways initiated by T cell receptor (TCR)-dependent and -independent stimuli, including IL-2, IL-15, and the mixture of phorbol dibutyrate and ionomycin. The RBC bioactivities preserve the antioxidant status and are capable of rescuing activated T cells from cell death induced by serum deprivation. They are not mediated by glycosylphosphatidylinositol-linked receptors or sialic acids, and kinetic studies revealed that they hasten the entrance into the cell cycle. By using cyclosporine A (CsA) and rapamycin (Rapa) we show that the RBC bioactivities are calcineurin-dependent. Thus, treatment of T cells with CsA, but not Rapa, impaired RBC bioactivities, and preincubation of RBC with CsA completely abolished their bioactivities. We have demonstrated that RBC carry out bioactivities that are sensitive to CsA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available